U.S. Market Expected to Reach USD 19.07 Billion and Europe Market to Hit USD 21.74 Billion by 2035 as Advanced Cardiometabolic Therapies Transform Diabetes Care.
U.S. Market Expected to Reach USD 19.07 Billion and Europe Market to Hit USD 21.74 Billion by 2035 as Advanced Cardiometabolic Therapies Transform Diabetes Care.